Invention Grant
- Patent Title: 4-imidazopyridazin-1-yl-benzamides as Btk inhibitors
-
Application No.: US16276161Application Date: 2019-02-14
-
Publication No.: US10934296B2Publication Date: 2021-03-02
- Inventor: Tjeerd A. Barf , Christiaan Gerardus Johannes Maria Jans , Adrianus Petrus Antonius de Man , Arthur A. Oubrie , Hans C. A. Raaijmakers , Johannes Bernardus Maria Rewinkel , Jan Gerard Sterrenburg , Jacobus C. H. M. Wijkmans
- Applicant: Merck Sharp & Dohme B.V.
- Applicant Address: NL Haarlem
- Assignee: Merck Sharp & Dohme B.V.
- Current Assignee: Merck Sharp & Dohme B.V.
- Current Assignee Address: NL Haarlem
- Agency: Covington & Burling LLP
- Agent Melody Wu; Jennifer L. Robbins
- Priority: EP11174578 20110719
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D519/00 ; A61K31/4985 ; A61K31/501 ; A61K31/506 ; A61K31/55 ; A61K31/5377
Abstract:
The present invention relates to 6-5 membered fused pyridine ring compounds according to Formula (I) or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds according to Formula (I) in the treatment of Bruton's Tyrosine Kinase (Btk) mediated disorders.
Public/Granted literature
- US20190276456A1 4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS Public/Granted day:2019-09-12
Information query
